Immunization against leukemia inhibitory factor and its receptor suppresses tumor formation of breast cancer initiating cells in BALB/c mouse

Immunotherapy is a promising approach for specific targeting of cancer cells. Leukemia inhibitory factor (LIF) regulates several features of cancers and cancer stem cells (CSCs) through binding to LIF receptor (LIFR). In this study, we investigated the consensus of LIF and LIFR immunization on the g...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanei, Zahra, Mehri, Nahid, Jamshidizad, Abbas, Joupari, Morteza Daliri, Shamsara, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351713/
https://www.ncbi.nlm.nih.gov/pubmed/32651426
http://dx.doi.org/10.1038/s41598-020-68158-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351713/
https://www.ncbi.nlm.nih.gov/pubmed/32651426
http://dx.doi.org/10.1038/s41598-020-68158-0

Ejemplares similares